Characteristic | Placebo | Desvenlafaxine | Desvenlafaxine |
---|---|---|---|
(n = 223) | 10 mg/d (n = 226) | 50 mg/d (n = 224) | |
Age, y | 42 ± 13 | 41 ± 14 | 43 ± 14 |
Age group, n (%) | |||
18-64 y | 215 (96) | 212 (94) | 213 (95) |
>64 y | 8 (4) | 14 (6) | 11 (5) |
Female, n (%) | 139 (62) | 135 (60) | 135 (60) |
Race, n (%) | |||
White | 176 (79) | 199 (88) | 177 (79) |
Black | 38 (17) | 20 (9) | 37 (17) |
Asian | 4 (2) | 3 (1) | 2 (1) |
Other | 5 (2) | 4 (2) | 8 (4) |
Weight, kg | 87 ± 24 | 88 ± 27 | 91 ± 26 |
Body mass index, kg/m 2 | 30 ± 7 | 31 ± 9 | 32 ± 8 |
Baseline HAM-D 17 score | 23 ± 3 | 23 ± 2 | 23 ± 3 |
Duration of current depressive episode, mo | 34 ± 81 | 26 ± 48 | 31 ± 76 |